128 related articles for article (PubMed ID: 8032305)
21. Construction and characterization of the chimeric monoclonal antibody E48 for therapy of head and neck cancer.
Brakenhoff RH; van Gog FB; Looney JE; van Walsum M; Snow GB; van Dongen GA
Cancer Immunol Immunother; 1995 Mar; 40(3):191-200. PubMed ID: 7728778
[TBL] [Abstract][Full Text] [Related]
22. Radioimmunodetection and therapy of breast cancer.
DeNardo SJ
Semin Nucl Med; 2005 Apr; 35(2):143-51. PubMed ID: 15765377
[TBL] [Abstract][Full Text] [Related]
23. Radioimmunotherapy in patients with head and neck squamous cell carcinoma: initial experience.
Colnot DR; Quak JJ; Roos JC; de Bree R; Wilhelm AJ; Snow GB; van Dongen GA
Head Neck; 2001 Jul; 23(7):559-65. PubMed ID: 11400244
[TBL] [Abstract][Full Text] [Related]
24. Phase I therapy study with (186)Re-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with head and neck squamous cell carcinoma.
Börjesson PK; Postema EJ; Roos JC; Colnot DR; Marres HA; van Schie MH; Stehle G; de Bree R; Snow GB; Oyen WJ; van Dongen GA
Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3961S-72S. PubMed ID: 14506195
[TBL] [Abstract][Full Text] [Related]
25. Current perspectives in the use of monoclonal antibodies for detection and treatment of head and neck tumors.
Quak J; van Dongen G
Eur Arch Otorhinolaryngol; 1994; 251(1):1-5. PubMed ID: 8179860
[TBL] [Abstract][Full Text] [Related]
26. Quantitative 89Zr immuno-PET for in vivo scouting of 90Y-labeled monoclonal antibodies in xenograft-bearing nude mice.
Verel I; Visser GW; Boellaard R; Boerman OC; van Eerd J; Snow GB; Lammertsma AA; van Dongen GA
J Nucl Med; 2003 Oct; 44(10):1663-70. PubMed ID: 14530484
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the biodistribution and the efficacy of monoclonal antibody 323/A3 labeled with either 131I or 186Re in human ovarian cancer xenografts.
Kievit E; van Gog FB; Schlüper HM; van Dongen GA; Pinedo HM; Boven E
Int J Radiat Oncol Biol Phys; 1997 Jul; 38(4):813-23. PubMed ID: 9240651
[TBL] [Abstract][Full Text] [Related]
28. Radioimmunoscintigraphy and radioimmunotherapy in cancer: principles and application.
Potamianos S; Varvarigou AD; Archimandritis SC
Anticancer Res; 2000; 20(2A):925-48. PubMed ID: 10810378
[TBL] [Abstract][Full Text] [Related]
29. Phase I therapy study of 186Re-labeled chimeric monoclonal antibody U36 in patients with squamous cell carcinoma of the head and neck.
Colnot DR; Quak JJ; Roos JC; van Lingen A; Wilhelm AJ; van Kamp GJ; Huijgens PC; Snow GB; van Dongen GA
J Nucl Med; 2000 Dec; 41(12):1999-2010. PubMed ID: 11138685
[TBL] [Abstract][Full Text] [Related]
30. Biodistribution and radioimmunotherapy of SCCHN in xenotransplantated SCID mice with a 131I-labelled anti-EpCAM monoclonal antibody.
Andratschke M; Gildehaus FJ; Johannson V; Schmitt B; Mack B; Reisbach G; Lang S; Lindhofer H; Zeidler R; Wollenberg B; Luebbers CW
Anticancer Res; 2007; 27(1A):431-6. PubMed ID: 17352264
[TBL] [Abstract][Full Text] [Related]
31. Cetuximab-based immunotherapy and radioimmunotherapy of head and neck squamous cell carcinoma.
Niu G; Sun X; Cao Q; Courter D; Koong A; Le QT; Gambhir SS; Chen X
Clin Cancer Res; 2010 Apr; 16(7):2095-105. PubMed ID: 20215534
[TBL] [Abstract][Full Text] [Related]
32. Fractionated radioimmunotherapy of human colon carcinoma xenografts with 131I-labeled monoclonal antibody CC49.
Buchsbaum D; Khazaeli MB; Liu T; Bright S; Richardson K; Jones M; Meredith R
Cancer Res; 1995 Dec; 55(23 Suppl):5881s-5887s. PubMed ID: 7493364
[TBL] [Abstract][Full Text] [Related]
33. The impact of tumour volume and other characteristics on uptake of radiolabelled monoclonal antibodies in tumour tissue of head and neck cancer patients.
de Bree R; Kuik DJ; Quak JJ; Roos JC; van den Brekel MW; Castelijns JA; van Wagtendonk FW; Greuter H; Snow GB; van Dongen GA
Eur J Nucl Med; 1998 Nov; 25(11):1562-5. PubMed ID: 9799354
[TBL] [Abstract][Full Text] [Related]
34. Localization and imaging of radiolabelled monoclonal antibody against squamous-cell carcinoma of the head and neck in tumor-bearing nude mice.
Quak JJ; Balm AJ; Brakkee JG; Scheper RJ; Haisma HJ; Braakhuis BJ; Meijer CJ; Snow GB
Int J Cancer; 1989 Sep; 44(3):534-8. PubMed ID: 2777416
[TBL] [Abstract][Full Text] [Related]
35. Biodistribution of 131I-labeled anti-CK8 monoclonal antibody in HNSCC in xenotransplanted SCID mice.
Andratschke M; Luebbers CW; Johannson V; Schmitt B; Mack B; Zeidler R; Lang S; Wollenberg B; Gildehaus FJ
Anticancer Res; 2011 Oct; 31(10):3315-21. PubMed ID: 21965741
[TBL] [Abstract][Full Text] [Related]
36. Biodistribution study of 188Re-labeled trisuccin-HuCC49 and trisuccin-HuCC49deltaCh2 conjugates in athymic nude mice bearing intraperitoneal colon cancer xenografts.
Safavy A; Khazaeli MB; Safavy K; Mayo MS; Buchsbaum DJ
Clin Cancer Res; 1999 Oct; 5(10 Suppl):2994s-3000s. PubMed ID: 10541333
[TBL] [Abstract][Full Text] [Related]
37. How far have we come with solid (nonhematologic) tumor radioimmunotherapy?
Breitz HB
J Nucl Med; 2000 Dec; 41(12):2011-4. PubMed ID: 11138686
[No Abstract] [Full Text] [Related]
38. Radioimmunotherapy with astatine-211 using chimeric monoclonal antibody U36 in head and neck squamous cell carcinoma.
Cheng J; Ekberg T; Engström M; Nestor M; Jensen HJ; Tolmachev V; Anniko M
Laryngoscope; 2007 Jun; 117(6):1013-8. PubMed ID: 17440426
[TBL] [Abstract][Full Text] [Related]
39. Safety and biodistribution of 99mTechnetium-labeled anti-CD44v6 monoclonal antibody BIWA 1 in head and neck cancer patients.
Stroomer JW; Roos JC; Sproll M; Quak JJ; Heider KH; Wilhelm BJ; Castelijns JA; Meyer R; Kwakkelstein MO; Snow GB; Adolf GR; van Dongen GA
Clin Cancer Res; 2000 Aug; 6(8):3046-55. PubMed ID: 10955783
[TBL] [Abstract][Full Text] [Related]
40. Biodistribution of 131I-, 186Re-, 177Lu-, and 88Y-labeled hLL2 (Epratuzumab) in nude mice with CD22-positive lymphoma.
Postema EJ; Frielink C; Oyen WJ; Raemaekers JM; Goldenberg DM; Corstens FH; Boerman OC
Cancer Biother Radiopharm; 2003 Aug; 18(4):525-33. PubMed ID: 14503946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]